Weed

WEED, Inc. operates as a holding company, which engages on the development and application of cannabis-derived compounds for the treatment of human disease. The company is headquartered in Tucson, Arizona and currently employs 2 full-time employees. The company went IPO on 2010-11-10. The firm and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.